NCT06170840View on ClinicalTrials.gov

A Study of QY101 Ointment in Subjects With Plaque Psoriasis

PHASE2RecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

May 17, 2023

Primary Completion Date

February 29, 2024

Study Completion Date

April 30, 2024

Conditions
Psoriasis
Interventions
DRUG

QY101Placebo/QY101 ointment

External use for BID

Trial Locations (1)

Unknown

RECRUITING

Shanghai Skin Disease Hospital, Shanghai

Sponsors
All Listed Sponsors
lead

E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.

INDUSTRY